Sibylle Dames

1.5k total citations
15 papers, 937 citations indexed

About

Sibylle Dames is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Sibylle Dames has authored 15 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Genetics. Recurrent topics in Sibylle Dames's work include RNA Interference and Gene Delivery (3 papers), Iron Metabolism and Disorders (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Sibylle Dames is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), Iron Metabolism and Disorders (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Sibylle Dames collaborates with scholars based in Germany, United States and Switzerland. Sibylle Dames's co-authors include Anke Klippel, Manuela Aleku, Kathrin Löffler, Jörg Kaufmann, Klaus Giese, Ansgar Santel, W. Arnold, Jens Endruschat, Oliver Keil and Melanie Fechtner and has published in prestigious journals such as The EMBO Journal, Blood and Oncogene.

In The Last Decade

Sibylle Dames

15 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sibylle Dames Germany	11	723	233	110	75	67	15	937
Yixuan Wang China	20	1.1k 1.6×	144 0.6×	159 1.4×	59 0.8×	27 0.4×	49	1.4k
Takeshi Namiki Japan	13	460 0.6×	134 0.6×	99 0.9×	194 2.6×	28 0.4×	58	1.0k
John Wiseman Sweden	15	588 0.8×	76 0.3×	130 1.2×	69 0.9×	40 0.6×	28	787
Xavier de Mollerat du Jeu United States	7	514 0.7×	166 0.7×	81 0.7×	32 0.4×	51 0.8×	14	819
Nuria Martí Gutiérrez Spain	9	633 0.9×	152 0.7×	77 0.7×	154 2.1×	11 0.2×	13	846
Krzysztof Poterlowicz United Kingdom	18	618 0.9×	140 0.6×	65 0.6×	196 2.6×	36 0.5×	21	978
Raheleh Rahbari United Kingdom	12	613 0.8×	342 1.5×	504 4.6×	61 0.8×	15 0.2×	27	1.1k
Perry L. Howard Canada	20	795 1.1×	78 0.3×	106 1.0×	161 2.1×	50 0.7×	35	1.1k
Shunji Jia China	19	675 0.9×	99 0.4×	87 0.8×	59 0.8×	18 0.3×	32	884
Kiran Batta United Kingdom	16	853 1.2×	63 0.3×	68 0.6×	100 1.3×	17 0.3×	29	1.1k

Countries citing papers authored by Sibylle Dames

Since Specialization

Citations

This map shows the geographic impact of Sibylle Dames's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibylle Dames with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibylle Dames more than expected).

Fields of papers citing papers by Sibylle Dames

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sibylle Dames. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibylle Dames. The network helps show where Sibylle Dames may publish in the future.

Co-authorship network of co-authors of Sibylle Dames

This figure shows the co-authorship network connecting the top 25 collaborators of Sibylle Dames. A scholar is included among the top collaborators of Sibylle Dames based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sibylle Dames. Sibylle Dames is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Rider, David A., Kathrin Löffler, Manuela Aleku, et al.. (2022). Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease. Atherosclerosis. 349. 240–247. 47 indexed citations

Schaeper, Ute, Bojun Li, Sibylle Dames, et al.. (2022). SLN140 a Small Interfering RNA Targeting Protein S Improves Hemostasis Potency in Hemophilia. Blood. 140(Supplement 1). 1670–1671. 3 indexed citations

Vadolas, Jim, Garrett Z. Ng, Kai Kysenius, et al.. (2021). SLN124, a GalNac‐siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron‐overload in a mouse model of β‐thalassaemia. British Journal of Haematology. 194(1). 200–210. 21 indexed citations

Schaeper, Ute, et al.. (2020). Targeting Protein S Using Small Interfering RNA Is Well Tolerated and Protects Mice with Hemophilia a from Acute Hemarthrosis. Blood. 136(Supplement 1). 20–21. 6 indexed citations

Schaeper, Ute, et al.. (2019). Liver-specific Bid silencing inhibits APAP-induced cell death in mice. APOPTOSIS. 24(11-12). 934–945. 10 indexed citations

Altamura, Sandro, Ute Schaeper, Sibylle Dames, et al.. (2019). SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1. HemaSphere. 3(6). e301–e301. 27 indexed citations

Altamura, Sandro, Martina U. Muckenthaler, Sibylle Dames, et al.. (2018). SLN124, a Galnac-siRNA Conjugate Targeting TMPRSS6, for the Treatment of Iron Overload and Ineffective Erythropoiesis Such As in Beta-Thalassemia. Blood. 132(Supplement 1). 2340–2340. 10 indexed citations

Bergmann, Thomas, Tanja Sappok, Albert Diefenbacher, et al.. (2015). Music-based Autism Diagnostics (MUSAD) – A newly developed diagnostic measure for adults with intellectual developmental disabilities suspected of autism. Research in Developmental Disabilities. 43-44. 123–135. 29 indexed citations

Santel, Ansgar, Manuela Aleku, Nadine Röder, et al.. (2010). Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis Models. Clinical Cancer Research. 16(22). 5469–5480. 81 indexed citations

10.

Santel, Ansgar, Manuela Aleku, Oliver Keil, et al.. (2006). RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Gene Therapy. 13(18). 1360–1370. 148 indexed citations

11.

Santel, Ansgar, Manuela Aleku, Oliver Keil, et al.. (2006). A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Therapy. 13(16). 1222–1234. 302 indexed citations

12.

Leenders, Frauke, Kristin Möpert, Ansgar Santel, et al.. (2004). PKN3 is required for malignant prostate cell growth downstream of activated PI 3‐kinase. The EMBO Journal. 23(16). 3303–3313. 81 indexed citations

13.

Dames, Sibylle, et al.. (2003). Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4. Oncogene. 22(43). 6748–6763. 115 indexed citations

14.

Wu, Deqing, et al.. (2001). Age-Specific Demographic Profiles of Longevity Mutants in Caenorhabditis elegans Show Segmental Effects. The Journals of Gerontology Series A. 56(8). B331–B339. 45 indexed citations

15.

Behlke, Mark A., Sibylle Dames, W. Hayes McDonald, et al.. (2000). Use of High Specific Activity StarFire™ Oligonucleotide Probes to Visualize Low-Abundance Pre-mRNA Splicing Intermediates in S. pombe. BioTechniques. 29(4). 892–897. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact